CELLULAR & MOLECULAR BIOLOGY LETTERS

Scope & Guideline

Bridging Gaps in Cellular Research for a Global Audience

Introduction

Immerse yourself in the scholarly insights of CELLULAR & MOLECULAR BIOLOGY LETTERS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1425-8153
PublisherBMC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationCELL MOL BIOL LETT / Cell. Mol. Biol. Lett.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'CELLULAR & MOLECULAR BIOLOGY LETTERS' is dedicated to advancing the understanding of cellular and molecular biology with a focus on disease mechanisms, therapeutic strategies, and innovative technologies. It encompasses a wide range of topics that reflect the interdisciplinary nature of modern biological research.
  1. Cancer Biology:
    Research on the molecular mechanisms underlying cancer progression, including studies on tumor microenvironments, cancer stem cells, and therapeutic resistance.
  2. Cellular Signaling and Regulation:
    Exploration of signaling pathways involved in cellular processes such as proliferation, differentiation, and apoptosis, with implications for disease treatment.
  3. Genomics and Epigenetics:
    Investigation of genetic and epigenetic factors influencing cell behavior, including studies on non-coding RNAs, methylation patterns, and gene editing technologies.
  4. Metabolic Disorders:
    Research focused on the molecular basis of metabolic diseases, particularly how cellular metabolism affects disease progression and treatment responses.
  5. Stem Cell Biology:
    Studies on the mechanisms of stem cell differentiation, regeneration, and their roles in tissue repair and cancer.
  6. Neurobiology and Neurodegenerative Diseases:
    Investigations into the cellular and molecular underpinnings of neurological disorders, including studies on neuroinflammation and synaptic plasticity.
  7. Innovative Therapeutics:
    Research into novel therapeutic approaches, including the use of stem cells, exosomes, and CRISPR technologies for disease treatment.
The journal has increasingly focused on several emerging themes that reflect the current trends in cellular and molecular biology. This section outlines these trending areas of research, highlighting their significance in advancing scientific knowledge and therapeutic development.
  1. RNA Modifications and Non-coding RNAs:
    A surge in research on RNA modifications, particularly N6-methyladenosine (m6A), and the roles of non-coding RNAs in gene regulation and cancer biology is evident.
  2. Targeted and Precision Medicine:
    Emerging studies emphasize personalized therapeutic approaches, particularly in cancer treatment, through the use of biomarkers and tailored therapies.
  3. Microbiome Influence on Disease:
    Research increasingly explores how the microbiome affects cellular processes and disease outcomes, revealing significant interactions between gut health and systemic diseases.
  4. Autophagy and Cellular Homeostasis:
    There is a growing interest in the role of autophagy in maintaining cellular health and its implications for various diseases, including cancer and neurodegeneration.
  5. CRISPR and Gene Editing Technologies:
    The application of CRISPR and other gene-editing technologies continues to expand, influencing research in genetic diseases, cancer, and therapeutic innovations.
  6. Cancer Immunotherapy:
    Research on the mechanisms of immune evasion by tumors and the development of immunotherapeutic strategies is gaining momentum, reflecting the shift towards harnessing the immune system in cancer treatment.
  7. Metabolic Reprogramming in Disease:
    An increasing focus on how metabolic changes in cells contribute to disease progression, particularly in cancer and metabolic disorders, is becoming a prominent theme.

Declining or Waning

While 'CELLULAR & MOLECULAR BIOLOGY LETTERS' continues to explore a diverse range of topics, certain areas of research have become less prominent in recent publications. This section highlights those themes that are waning in focus.
  1. Traditional Pharmacology:
    Research that emphasizes conventional drug development and pharmacodynamics has seen a decline, with a shift towards more innovative and targeted therapeutic strategies.
  2. Basic Cellular Mechanisms:
    Studies solely focused on fundamental cellular processes without a clear application to disease or therapeutic relevance appear to be less frequent.
  3. In vitro Studies without Translational Relevance:
    There seems to be a decrease in in vitro studies that do not connect findings to potential clinical applications or translational research.
  4. Animal Models with Limited Human Relevance:
    Research utilizing animal models that do not effectively mimic human disease conditions is becoming less common, as the field emphasizes more relevant translational models.

Similar Journals

Cell Communication and Signaling

Innovating Understanding in Cell Biology and Signaling
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

Protein & Cell

Unveiling Innovations in Drug Discovery and Biotechnology
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Pioneering Research for a Deeper Biological Insight
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 1084-9521Frequency: 12 issues/year

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY is a premier journal published by Academic Press Ltd - Elsevier Science Ltd, focusing on the vital domains of cell and developmental biology. With an impact factor that reflects its rigorous contributions to the field, this journal embodies the highest standards of academic excellence, currently ranking in the Q1 quartile for both Cell Biology and Developmental Biology categories as of 2023. Researchers and practitioners will appreciate its robust Scopus ranking, placing it within the top tiers of developmental biology and cell biology, with percentile ranks of 94th and 90th respectively, showcasing the journal's influential presence in the scientific community. The journal aims to disseminate comprehensive reviews, cutting-edge research articles, and significant advances in the understanding of cellular mechanisms and developmental processes, thereby catering to a diverse audience that includes researchers, scholars, and students dedicated to the life sciences. Given its commitment to open access, SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY promotes widespread dissemination of knowledge, enhancing collaborative research efforts and driving innovation across biological disciplines.

CELL BIOLOGY INTERNATIONAL

Illuminating Cellular Processes for a Healthier Tomorrow
Publisher: WILEYISSN: 1065-6995Frequency: 12 issues/year

CELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.

CYTOTECHNOLOGY

Advancing Cytotechnology: Pioneering Research for Tomorrow's Innovations.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

BMC Molecular and Cell Biology

Fostering collaboration in the realm of molecular and cell science.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

CELLULAR AND MOLECULAR LIFE SCIENCES

Advancing the Frontiers of Cellular and Molecular Discovery
Publisher: SPRINGER BASEL AGISSN: 1420-682XFrequency: 24 issues/year

CELLULAR AND MOLECULAR LIFE SCIENCES, published by SPRINGER BASEL AG, stands as a premier journal dedicated to advancing the field of cellular and molecular biology. With an impressive 2023 impact factor reflected in its Q1 rankings across key categories—including Cell Biology, Molecular Biology, and Pharmacology—it serves as a critical platform for researchers aiming to disseminate high-quality findings in these dynamic fields. Operated under an open access framework, the journal allows broader accessibility to groundbreaking research, fostering collaboration amongst scientists globally. Based in Switzerland, CELLULAR AND MOLECULAR LIFE SCIENCES has been at the forefront of scientific publishing since 1952, adapting to contemporary scientific challenges and trends, ultimately shaping the future of life sciences.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Illuminating the Path of Molecular Discoveries
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

Cell Discovery

Showcasing Innovations that Transform Life Sciences
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

DNA AND CELL BIOLOGY

Illuminating the Path of Cellular Advancements
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.